Harold E. Selick

Insider Reports History

Entity
Individual
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harold E. Selick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Director Common Stock 28K $52.9K $1.89 Mar 7, 2024 Direct
Molecular Templates, Inc. Director Stock Option (right to buy) 1K Oct 27, 2023 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 0 Mar 7, 2024 Direct

Insider Reports Filed by Harold E. Selick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTGX Protagonist Therapeutics, Inc Mar 7, 2024 2 $12.3K 4 Mar 11, 2024 Director
PTGX Protagonist Therapeutics, Inc Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
MTEM Molecular Templates, Inc. Oct 27, 2023 1 $0 4 Oct 31, 2023 Director
PTGX Protagonist Therapeutics, Inc Apr 10, 2023 2 $5.39K 4 Apr 11, 2023 Director
PTGX Protagonist Therapeutics, Inc Jan 16, 2023 1 $0 4 Jan 18, 2023 Director
MTEM Molecular Templates, Inc. Jun 3, 2022 1 $0 4 Jun 6, 2022 Director
PTGX Protagonist Therapeutics, Inc May 26, 2022 1 $0 4 May 27, 2022 Director
MTEM Molecular Templates, Inc. Jun 3, 2021 1 $0 4 Jun 4, 2021 Director
PTGX Protagonist Therapeutics, Inc May 27, 2021 1 $0 4 May 28, 2021 Director